Sitara Peroxide Limited (PSX:SPL)
Pakistan · Delayed Price · Currency is PKR 49.63
+0.67 (1.37%)
At close: Nov 6, 2026
Sitara Peroxide Income Statement
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| - | - | - | 14.9 | 824 | 1,743 | |
Revenue Growth | - | - | - | -98.19% | -52.72% | -6.58% |
Cost of Revenue | - | - | - | 215.36 | 1,114 | 1,806 |
Gross Profit | - | - | - | -200.45 | -290.39 | -63.2 |
Selling, General & Admin | 238.94 | 240.41 | 254.75 | 90.68 | 258.23 | 244.78 |
Other Operating Expenses | - | - | - | 0.2 | 12.64 | - |
Operating Expenses | 321.44 | 322.91 | 319.52 | 169.86 | 425.29 | 278.79 |
Operating Income | -321.44 | -322.91 | -319.52 | -370.32 | -715.68 | -341.99 |
Interest Expense | -38.23 | -38.25 | -4.73 | -24.55 | -62.18 | -46.53 |
Interest & Investment Income | - | - | - | 0.03 | 0.08 | 0.28 |
Currency Exchange Gain (Loss) | - | - | - | - | - | 0.03 |
Other Non Operating Income (Expenses) | 3.27 | -0.43 | -0.01 | -0.4 | -5.12 | -4.44 |
EBT Excluding Unusual Items | -356.41 | -361.59 | -324.25 | -395.23 | -782.9 | -392.65 |
Gain (Loss) on Sale of Assets | 115.36 | 115.36 | - | 89.52 | - | 5.69 |
Other Unusual Items | 260.02 | 260.02 | - | - | - | - |
Pretax Income | 19.27 | 14.09 | -311.35 | -305.71 | -782.9 | -386.96 |
Income Tax Expense | -134.84 | -133.37 | -88.84 | -136.36 | -50.34 | -45.75 |
Net Income | 154.11 | 147.46 | -222.52 | -169.35 | -732.56 | -341.21 |
Net Income to Common | 154.11 | 147.46 | -222.52 | -169.35 | -732.56 | -341.21 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 55 | 55 | 55 | 55 | 55 | 55 |
Shares Outstanding (Diluted) | 55 | 55 | 55 | 55 | 55 | 55 |
Shares Change | 0.08% | - | - | - | - | - |
EPS (Basic) | 2.80 | 2.68 | -4.04 | -3.07 | -13.30 | -6.19 |
EPS (Diluted) | 2.80 | 2.68 | -4.04 | -3.07 | -13.30 | -6.19 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -113.29 | -87.1 | 19.65 | -5.11 | -203.39 | 3.75 |
Free Cash Flow Per Share | -2.06 | -1.58 | 0.36 | -0.09 | -3.69 | 0.07 |
Gross Margin | - | - | - | - | -35.24% | -3.63% |
Operating Margin | - | - | - | -2485.23% | -86.85% | -19.62% |
Profit Margin | - | - | - | -1136.52% | -88.90% | -19.58% |
Free Cash Flow Margin | - | - | - | -34.27% | -24.68% | 0.21% |
EBITDA | -143.81 | -145.47 | -139.26 | -186.5 | -527.85 | -111.93 |
EBITDA Margin | - | - | - | - | -64.06% | -6.42% |
D&A For EBITDA | 177.64 | 177.44 | 180.26 | 183.82 | 187.82 | 230.07 |
EBIT | -321.44 | -322.91 | -319.52 | -370.32 | -715.68 | -341.99 |
EBIT Margin | - | - | - | - | -86.85% | -19.62% |
Advertising Expenses | - | - | - | - | - | 0.16 |